TOP
Dedicated to creating automated and intelligent biotechnology applications
Accelerating life sciences research and development to ensure biomedical security
GentleGen is committed to creating automated and intelligent biotechnology applications, combining advanced automation technology to create an intelligent one-stop gene service technology platform for gene synthesis, oligonucleotide synthesis, Sanger sequencing, high-throughput sequencing, gene editing and protein expression, accelerating the progress of life sciences R&D, and upgrading the synthetic biology industry. Meanwhile, GentleGen has established a comprehensive biopharmaceutical safety evaluation system for nucleic acid drugs, cellular and gene therapeutic drugs, gene editing drugs and protein drugs, from early R&D to clinical stage, to ensure the safety of biopharmaceuticals. We are committed to contributing to global health and green development, and are ready to be a reliable partner in the biopharmaceutical and synthetic biology industries.
2022
Established in
30
Authorized Patents
100
Number of employees
Development History
We are committed to contributing to global health and green development, and would like to be a reliable partner in the biopharmaceutical and synthetic biology industry.
Corporate Culture
Committed to contributing to global health and green development
Honor
Customer first, win-win cooperation, honesty and integrity, continuous innovation.